Gordon and Betty Moore Foundation - Clinical Quality Measures to Improve Diagnosis

Grants will be awarded to support the development of innovative clinical quality measures that promote excellence in the diagnosis of three categories of disease that comprise the most common and most harmful diagnostic errors: acute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia), and cancer (such as lung and colorectal cancer).

This funding round prioritizes measures intended for use in the MIPS (Merit-based Incentive Payment System) and the MVP (MIPS Value Pathway) and applications that utilize Qualified Clinical Data Registries (QCDRs). However, interested applicants working on other quality measures and data sources are still encouraged to apply.

There must be a proposed measure of diagnostic performance based on obtainable evidence in one or more of the three priority categories for this grant opportunity. The expected work requires two interlinked activities: 1) developing the rationale for a measure and 2) operationalizing the measure into an algorithm. Prior work in measure development is beneficial but not required.

The foundation is seeking measures that can eventually be developed into fully specified performance indicators that: address a performance improvement opportunity and fill a measurement gap; align with evidence; focus on outcomes; can be easily and reliably retrieved or designed into commonly available data sources; are likely to be high-value; and rely on a data source appropriate for pilot testing and accessible by the grantee for this purpose.

Applicants must be familiar with the U.S. healthcare system and have grant outputs feasible for implementation in the U.S.